Eli Lilly Director Gabrielle Sulzberger Acquires Shares via Board Fee Deferral

Transaction Overview

On September 21, 2026, Gabrielle Sulzberger, a member of the Board of Directors of Eli Lilly & Co ($LLY), acquired 4.2565 shares of common stock at a price of $1,164.89 per share, totaling approximately $4,958.35.

Transaction Nature

According to the footnote disclosures, the shares were acquired under the Lilly Directors' Deferral Plan. At the director's election, cash compensation earned for board service was deferred into stock units that will be settled in common shares following separation from service. This represents a routine equity-in-lieu-of-cash compensation election rather than an open-market purchase.

Holdings and Market Significance

Following this transaction, Sulzberger directly holds 3,012.4473 shares of Eli Lilly common stock. Due to the small dollar amount and the programmatic nature of director compensation deferrals, this filing carries low informational value for market direction.